Mental Disorder Treatment Market
- 2026 年市場規模
- USD 75.1 Bn
- 2033 年預估規模
- USD 116.7 Bn
- 年複合成長率 CAGR
- 6.6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Mental Disorder Treatment Market, By Disorder Type (Depression, Bipolar Disorder, Schizophrenia, Dementia, Post-traumatic Stress Disorder, Others), By Medication (Anti-depressants, Anti-anxiety, Mood Stabilizing Medication, Antipsychotic Medications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
The mental disorder include various different types of mental disorders such as depression, bipolar disorder, schizophrenia, dementia, post traumatic disorders, and others. These mental disorders are treated with the help of medications or psycho-therapies. Moreover, various medications used for the treatment of these mental disorders include anti-depressants, anti-anxiety medications, anti-psychotic medications, and mood stabilizing medication.
Market Dynamics
Key companies are focusing on product launches for the treatment of mental disorders such as depression, bipolar disorders to strengthen their position in the global mental disorder treatment market. For instance, in 2017, Lupin Limited, launched its anti-depressant, Bupropion Hydrochloride extended release tablets, indicated for the treatment of major depressive disorder, in the U.S. market.
Key features of the study
• This report studies the current scenario as well as the future potential of the global mental disorder treatment market. The market for is segmented on basis of disorder type, medication, distribution channel, and region.
• This report provides in-depth analysis of the global mental disorder treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR) (%) for the forecast period (2026-2033)
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
• It profiles leading players in the global mental disorder treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
• The global mental disorder treatment market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
• Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global mental disorder treatment market
Market Segmentation
• By Disorder Type (Revenue, USD Bn, 2021-2033)
o Depression
o Bipolar Disorder
o Schizophrenia
o Dementia
o Post-traumatic stress disorder
o Others
• By Medication (Revenue, USD Bn, 2021-2033)
o Anti-depressants
o Anti-anxiety
o Mood Stabilizing Medication
o Antipsychotic Medications
• By Distribution Channel (Revenue, USD Bn, 2021-2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• Global Mental Disorder Treatment Market, By Region: (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Allergan plc
o Eli Lilly and Company
o VistaGen Therapeutics
o Sanofi S.A
o Novartis International AG
o Mylan N.V.
o Amneal Pharmaceuticals LLC
o Cipla Ltd
o Sun Pharmaceutical Industries Ltd.
o Glenmark Pharmaceuticals Limited
o Lupin Limited
o Janssen Pharmaceutica
o Bristol Myers Squibb
o Sumitomo Dainippon Pharma Co., Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Disorder Type
Market Snapshot, By Medication
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Drivers
o Restraints
o Opportunities
o Impact Analysis
o Key Developments
o New Product Launches/Approvals
o Merger-Acquisition Scenario
o Regulatory Scenario
o Pipeline Analysis
o Epidemiology
o PEST Analysis
o Reimbursement
4. Global Mental Disorder Treatment Market, By Disorder Type, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026, and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Depression
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Bipolar Disorder
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Schizophrenia
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Dementia
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Post-traumatic Stress Disorder
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Others
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
5. Global Mental Disorder Treatment Market, By Medication, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026, and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Anti-depressants
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Anti-anxiety
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Mood Stabilizing Medication
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Antipsychotic Medications
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
6. Global Mental Disorder Treatment Market, By Distribution Channel, 2021–2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
7. Global Mental Disorder Treatment Market, By Region, 2021-2033 (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2022 - 2033
o North America
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o U.S.
o Canada
o Latin America
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Company Profiles
Allergan plc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Eli Lilly and Company
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
VistaGen Therapeutics
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sanofi S.A
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Novartis International AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Mylan N.V.
Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Amneal Pharmaceuticals LLC
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Cipla Ltd
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sun Pharmaceutical Industries Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Glenmark Pharmaceuticals Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Lupin Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Janssen Pharmaceutica
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Bristol Myers Squibb
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sumitomo Dainippon Pharma Co., Ltd
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
9. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
10. References and Research Methodology
o References
o Research Methodology
o About us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們